Sunhwa Shin

Title: Innovations by Sunhwa Shin in Genetic Engineering

Introduction

Sunhwa Shin is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of genetic engineering, particularly through her innovative patent related to intron fragments. Her work is expected to have a substantial impact on therapeutic gene delivery systems.

Latest Patents

Sunhwa Shin holds a patent for novel intron fragments. These intron fragments can increase gene expression to levels equal to or higher than those achieved by full-length introns. They maintain their ability to enhance gene expression even when combined with various types of promoters and splicing donors. Notably, these intron fragments enable the loading of larger transgenes in genetic information delivery systems, such as adeno-associated viruses (AAVs) and rhabdoviruses. This innovation is anticipated to extend the range of therapeutic genes available for research and treatment.

Career Highlights

Sunhwa Shin is currently associated with Neuracle Genetics Inc., where she continues to advance her research in genetic engineering. Her work has garnered attention for its potential applications in medicine and biotechnology.

Collaborations

Sunhwa collaborates with notable colleagues, including Hoon Young Kong and Jong-Mook Kim. Their combined expertise contributes to the innovative environment at Neuracle Genetics Inc.

Conclusion

Sunhwa Shin's contributions to genetic engineering through her patent on intron fragments highlight her role as a leading inventor in the field. Her work promises to enhance therapeutic gene delivery systems and expand the possibilities for genetic research and treatment.